More than 14,000 people in Fresno County live with Alzheimer’s, and an estimated 720,000 Californians face the disease statewide. That’s why the California Institute for Regenerative Medicine (CIRM)—the state agency funding regenerative medicine research—joined the Alzheimer’s Association Walk to End Alzheimer’s in Fresno/Madera to highlight the cell and gene therapy research we support. More than … Continue reading California advancing our understanding of Alzheimer’s disease using stem cells
CIRM Showcases Strategic Vision at 7th Annual Alpha Clinics Network Symposium
Leveraging CIRM Infrastructure to Improve Accessibility Panel - From left to right: Noah Federman, MD (moderator), Catriona Jamieson, MD, PhD, Mehrdad Abedi, MD, Daniela Bota, MD, PhD, Thomas Buchanan, MD, Brian Fury, MS, Dhruv Sareen, PhD, and Taby Ahsan, PhD The California Institute for Regenerative Medicine (CIRM) hosted the 7th Annual CIRM Alpha Clinics Network … Continue reading CIRM Showcases Strategic Vision at 7th Annual Alpha Clinics Network Symposium
Elpida Therapeutics’ Study on Rare Nerve Disease CMT4J
CIRM awarded Elpida Therapeutics a $3.9 million grant in December 2023 to support a pioneering preclinical study on Charcot Marie Tooth disease type 4J (CMT4J).
Stem Cell Awareness: What are stem cells and why research is important
Have you heard of stem cells but don't know what they are or why they are essential in medical research? In celebration of Stem Cell Awareness Day, the second Wednesday in October that is dedicated to educating about the importance of stem cells, the California Institute for Regenerative Medicine (CIRM) is providing this guide on … Continue reading Stem Cell Awareness: What are stem cells and why research is important
Solano Student’s Life-Saving Bone Marrow Match Begins with One Swab
Image Source: Jose Solorio Jose Solorio, a Solano Community College student and participant in CIRM’s COMPASS training program, has firsthand experience in witnessing the power of stem cells as a donor after he became a bone marrow match. Hands-on research As part of CIRM's COMPASS program, which provides hands‑on research experience across 16 programs statewide … Continue reading Solano Student’s Life-Saving Bone Marrow Match Begins with One Swab
CIRM’s Key Recommendations from Strategic Allocation Framework
The California Institute for Regenerative Medicine (CIRM) presented key recommendations from its Strategic Allocation Framework (SAF), offering a structured, data‑driven approach to guide funding decisions and maximize impact. These recommendations, shared with the Independent Citizens’ Oversight Committee, move CIRM closer to its mission to accelerate the development and delivery of innovative regenerative medicine therapies. Evolving … Continue reading CIRM’s Key Recommendations from Strategic Allocation Framework
UC San Diego Gene Therapy Initiative Symposium fueling progress in the field
Enthusiasm ran high at the inaugural UC San Diego Gene Therapy Initiative Symposium at the Roth Auditorium at the Sanford Consortium. Researchers, clinicians, and patient advocates gathered to share new discoveries in gene therapy—a rapidly evolving field that is reshaping modern medicine. CIRM served as a platinum sponsor of the event. Era of progress The … Continue reading UC San Diego Gene Therapy Initiative Symposium fueling progress in the field
CIRM Supports Groundbreaking Gene Therapy for AML and MDS
Image source: Canva The California Institute for Regenerative Medicine (CIRM) recently awarded $8 million to Rochelle Emery, MD, at Senti Bio to advance a clinical trial for a novel therapy targeting two forms of blood cancer, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). About AML and MDS Both cancers have a five‑year survival rate … Continue reading CIRM Supports Groundbreaking Gene Therapy for AML and MDS
Strategic Framework Impacts the Future of CIRM’s Research Funding
As the regenerative medicine field rapidly evolves, CIRM faces a key challenge: investing the remaining $3.86 billion in ways that deliver the greatest impact for Californians. To meet this challenge, CIRM launched the Strategic Allocation Framework (SAF) to prioritize resources and maximize the potential of regenerative medicine breakthroughs. What is the SAF? The SAF uses … Continue reading Strategic Framework Impacts the Future of CIRM’s Research Funding
CIRM Supports Gene Therapy for Rare Heart Disorder
Image Source: American Heart Association Journals The California Institute for Regenerative Medicine (CIRM) awarded $4 million to support a gene therapy for rare life-threatening genetic disorder. A rare heart disorder Known as desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM), the genetic disorder is a rare heart disorder. This preclinical award went to Deborah D. Ascheim, … Continue reading CIRM Supports Gene Therapy for Rare Heart Disorder